Moody’s downgrades Senegal to Caa1 amid rising debt concerns
On Monday, Goldman Sachs analysts reiterated a Sell rating for Science Applications (NASDAQ:SAIC) International Corp. (NASDAQ: SAIC) stock, maintaining a price target of $94.00. This represents one of the more bearish views on Wall Street, as InvestingPro data shows analyst targets ranging from $94 to $155, with the stock currently trading at $104.90. The decision follows the company’s release of its first-quarter fiscal 2026 results, which showed mixed performance against market expectations.
SAIC reported first-quarter revenue of $1.88 billion, aligning closely with the FactSet consensus of $1.87 billion. However, the company’s adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) fell short of expectations, coming in at $157 million compared to the consensus estimate of $172 million. This resulted in an 8.4% adjusted EBITDA margin, missing the analysts’ and consensus expectations by 80 basis points. InvestingPro analysis indicates the company suffers from weak gross profit margins, currently at 11.9%, while maintaining a Fair Value significantly above current trading levels.
While the company’s organic revenue grew by 2% year-over-year, its adjusted earnings per share (EPS) of $1.92 were below the anticipated $2.12. Additionally, SAIC’s free cash flow was negative at $44 million, contrasting sharply with the consensus expectation of $116 million.
Despite these shortfalls, SAIC reiterated its full-year fiscal 2026 guidance. The company expects revenue to range between $7.60 billion and $7.75 billion, with an adjusted EBITDA margin of 9.4% to 9.6%. Adjusted EPS is projected to be between $9.10 and $9.30, while adjusted free cash flow is anticipated to be between $510 million and $530 million.
In the quarter, SAIC repurchased $142 million of its stock, reflecting its commitment to returning value to shareholders. InvestingPro data shows management has been aggressively buying back shares, contributing to a high shareholder yield. The company’s total book-to-bill ratio was reported at 1.30x, indicating a healthy level of new business relative to billings. For deeper insights into SAIC’s financial health and valuation metrics, including 8 additional ProTips and comprehensive analysis, subscribers can access the full Pro Research Report.
In other recent news, Science Applications International Corporation (SAIC) announced its first-quarter earnings, which fell short of analyst expectations. The company reported adjusted earnings per share of $1.92, missing the consensus estimate of $2.16. However, revenue for the quarter matched analyst projections, coming in at $1.88 billion. SAIC experienced a 12% decline in net income, amounting to $68 million, and a 5% drop in adjusted EBITDA, which reached $157 million. The company attributed these declines to "timing and volume mix" in its contract portfolio. Despite these challenges, SAIC reaffirmed its fiscal 2026 outlook, forecasting revenue between $7.6 billion and $7.75 billion and adjusted earnings per share of $9.10 to $9.30. The company’s net bookings for the first quarter totaled $2.4 billion, resulting in a book-to-bill ratio of 1.3. At the end of the quarter, SAIC’s total backlog stood at $22.3 billion.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.